Late Recurrences in Early Breast Cancer: For Whom and How Long Is Endocrine Therapy Beneficial?

Breast Care - Switzerland
doi 10.1159/000362482
Full Text
Abstract

Available in full text

Categories
SurgeryOncology
Date
Authors
Publisher

S. Karger AG

Related search

Neoadjuvant Endocrine Therapy: For Whom, for How Long?

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2012English

The Optimal Duration and Selection of Adjuvant Endocrine Therapy for Breast Cancer: How Long Is Enough?

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2014English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

How to Improve Endocrine Therapy of Breast Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

How to Overcome Endocrine Resistance in Early and Metastatic Breast Cancer

Chronicles of Oncology
2018English

Endocrine Therapy of Breast Cancer

2008English

Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer

Current Treatment Options in Oncology
OncologyPharmacology
2018English

COX2 Expression in Prognosis and in Prediction to Endocrine Therapy in Early Breast Cancer Patients

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy